{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:01:24Z","timestamp":1772121684244,"version":"3.50.1"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.toxicon.2023.107206","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T11:47:48Z","timestamp":1687607268000},"page":"107206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Global parameter optimisation and sensitivity analysis of antivenom pharmacokinetics and pharmacodynamics"],"prefix":"10.1016","volume":"232","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5783-5832","authenticated-orcid":false,"given":"Natalie","family":"M Morris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6873-0841","authenticated-orcid":false,"given":"Johanna","family":"A Blee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Hauert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2023.107206_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.632687","article-title":"Immunogenicity risk profile of nanobodies","volume":"12","author":"Ackaert","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.toxicon.2023.107206_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2022.106955","article-title":"Proteomics and histological assessment of an organotypic model of human skin following exposure to Naja nigricollis venom","volume":"220","author":"Ahmadi","year":"2022","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2023.107206_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01589","article-title":"Camelid single-domain antibodies: historical perspective and future outlook","volume":"8","author":"Arbabi-Ghahroudi","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.toxicon.2023.107206_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s40364-021-00332-6","article-title":"A comprehensive comparison between camelid nanobodies and single chain variable fragments","volume":"9","author":"Asaadi","year":"2021","journal-title":"Biomarker Res."},{"key":"10.1016\/j.toxicon.2023.107206_bib5","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1080\/15563650.2020.1726377","article-title":"Snake bites by European vipers in Mainland France in 2017-2018: comparison of two antivenoms Viperfav\u00ae and Viperatab","volume":"58","author":"Boels","year":"2020","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.toxicon.2023.107206_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4320175","article-title":"Developing small molecule therapeutics for the initial and adjunctive treatment of snakebite","author":"Bulfone","year":"2018","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.toxicon.2023.107206_bib7","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1208\/s12248-012-9369-y","article-title":"Physiochemical and biochemical factors influencing the pharmacokinetics of antibody therapeutics","volume":"14","author":"Bumbaca","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.toxicon.2023.107206_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/15563650.2014.974263","article-title":"Comparison of F(ab\u2019)2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial","volume":"53","author":"Bush","year":"2015","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.toxicon.2023.107206_bib9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2460\/javma.259.5.503","article-title":"Retrospective comparison of three antivenoms for the treatment of dogs with crotalid envenomation","volume":"259","author":"Carotenuto","year":"2021","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.toxicon.2023.107206_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0041-0101(02)00283-0","article-title":"Intramuscular administration of antivenoms in experimental envenomation by Bothrops asper: comparison between Fab and IgG","volume":"41","author":"Chaves","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2023.107206_bib11","doi-asserted-by":"crossref","first-page":"E104","DOI":"10.3390\/toxins11020104","article-title":"Exploring the diversity and novelty of toxin genes in Naja sumatrana, the equatorial spitting cobra from Malaysia through de novo venom-gland transcriptomics","volume":"11","author":"Chong","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2023.107206_bib12","article-title":"Machine learning and artificial intelligence in physiologically based pharmacokinetic modeling","author":"Chou","year":"2022","journal-title":"Toxicological Sciences kfac101"},{"key":"10.1016\/j.toxicon.2023.107206_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1067\/mem.2001.113372","article-title":"Efficacy, safety, and use of snake antivenoms in the United States","volume":"37","author":"Dart","year":"2001","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.toxicon.2023.107206_bib14","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1124\/dmd.119.086488","article-title":"Mechanisms influencing the pharmacokinetics and disposition of monoclonal antibodies and peptides","volume":"47","author":"Datta-Mannan","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxicon.2023.107206_bib15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/bcp.12739","article-title":"Adverse reactions to snake antivenom, and their prevention and treatment","volume":"81","author":"de Silva","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.toxicon.2023.107206_bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ki.1979.138","article-title":"Macromolecule transport across glomerular capillaries: application of pore theory","volume":"16","author":"Deen","year":"1979","journal-title":"Kidney Int."},{"key":"10.1016\/j.toxicon.2023.107206_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.856961","article-title":"Physiological considerations for modeling in vivo antibody-target interactions","volume":"13","author":"Dunlap","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.toxicon.2023.107206_bib18","doi-asserted-by":"crossref","first-page":"876","DOI":"10.4269\/ajtmh.16-0842","article-title":"Bites by the monocled cobra, Naja kaouthia, in chittagong division, Bangladesh: epidemiology, clinical features of envenoming and management of 70 identified cases","volume":"96","author":"Faiz","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2023.107206_bib19","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijbiomac.2021.06.043","article-title":"Engineering of single-domain antibodies for next-generation snakebite antivenoms","volume":"185","author":"Fernandes","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.toxicon.2023.107206_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fevo.2019.00218","article-title":"Multifunctional toxins in snake venoms and therapeutic implications: from pain to hemorrhage and necrosis","volume":"7","author":"Ferraz","year":"2019","journal-title":"Front. Ecol. Evol."},{"key":"10.1016\/j.toxicon.2023.107206_bib21","doi-asserted-by":"crossref","first-page":"10679","DOI":"10.1073\/pnas.97.20.10679","article-title":"Breaking the affinity ceiling for antibodies and T cell receptors","volume":"97","author":"Foote","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.toxicon.2023.107206_bib22","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1073\/pnas.92.5.1254","article-title":"Kinetic and affinity limits on antibodies produced during immune responses","volume":"92","author":"Foote","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.toxicon.2023.107206_bib23","first-page":"1","article-title":"Control of venom-induced tissue injury in copperhead snakebite patients: a post hoc sub-group analysis of a clinical trial comparing F(ab\u2019)2 to Fab antivenom","volume":"0","author":"Gerardo","year":"2021","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.toxicon.2023.107206_bib24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.sbi.2012.06.001","article-title":"Structural insights for engineering binding proteins based on non-antibody scaffolds","volume":"22","author":"Gilbreth","year":"2012","journal-title":"Curr. Opin. Struct. Biol., Eng. Des.\/Membr."},{"key":"10.1016\/j.toxicon.2023.107206_bib25","first-page":"301","article-title":"Systems biology for organotypic cell cultures","volume":"34","author":"Grego","year":"2017","journal-title":"ALTEX - Alternatives to animal experimentation"},{"key":"10.1016\/j.toxicon.2023.107206_bib26","article-title":"Snakebite envenoming","volume":"3","author":"Guti\u00e9rrez","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.toxicon.2023.107206_bib27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2165\/00003088-200342080-00002","article-title":"Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation","volume":"42","author":"Guti\u00e9rrez","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.toxicon.2023.107206_bib28","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.nantod.2013.11.001","article-title":"A computational framework for identifying design guidelines to increase the penetration of targeted nanoparticles into tumors","volume":"8","author":"Hauert","year":"2013","journal-title":"Nano Today"},{"key":"10.1016\/j.toxicon.2023.107206_bib29","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1016\/j.molimm.2008.04.011","article-title":"VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI","volume":"45","author":"Hmila","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.toxicon.2023.107206_bib30","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1096\/fj.09-148213","article-title":"A bispecific nanobody to provide full protection against lethal scorpion envenoming","volume":"24","author":"Hmila","year":"2010","journal-title":"Faseb. J."},{"key":"10.1016\/j.toxicon.2023.107206_bib31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0041-0101(02)00336-7","article-title":"The clinical significance of venom detection in patients of cobra snakebite","volume":"41","author":"Hung","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2023.107206_bib32","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0041-0101(98)00144-5","article-title":"Pharmacokinetics of 125I-labelled IgG, F(ab')2 and Fab fractions of scorpion and snake antivenins: merits and potential for therapeutic use","volume":"36","author":"Ismail","year":"1998","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2023.107206_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/toxins11010053","article-title":"Toxin neutralization using alternative binding proteins","volume":"11","author":"Jenkins","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2023.107206_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.00703","article-title":"Cost of manufacturing for recombinant snakebite antivenoms","volume":"8","author":"Jenkins","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.toxicon.2023.107206_bib35","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3390\/toxins10120534","article-title":"Biosynthetic oligoclonal antivenom (BOA) for snakebite and next-generation treatments for snakebite victims","volume":"10","author":"Kini","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2023.107206_bib36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/toxins13030211","article-title":"Comparison of preclinical properties of several available antivenoms in the search for effective treatment of Vipera ammodytes and Vipera berus envenoming","volume":"13","author":"Kurtovi\u0107","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2023.107206_bib37","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.3390\/cancers13184620","article-title":"Improving biologics' effectiveness in clinical oncology: from the combination of two monoclonal antibodies to oligoclonal antibody mixtures","volume":"13","author":"Larbouret","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.toxicon.2023.107206_bib38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/15569543.2016.1220397","article-title":"Toxin synergism in snake venoms","volume":"35","author":"Laustsen","year":"2016","journal-title":"Toxin Rev."},{"key":"10.1016\/j.toxicon.2023.107206_bib39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.toxicon.2018.03.004","article-title":"Pros and cons of different therapeutic antibody formats for recombinant antivenom development","volume":"146","author":"Laustsen","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2023.107206_bib40","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0041-0101(00)00209-9","article-title":"Comparison between IgG and F(ab')2 polyvalent antivenoms: neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions","volume":"39","author":"Le\u00f3n","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2023.107206_bib41","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0041-0101(97)00034-2","article-title":"Immunoglobulin G and F(ab')2 polyvalent antivenoms do not differ in their ability to neutralize hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom","volume":"35","author":"Le\u00f3n","year":"1997","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2023.107206_bib42","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4269\/ajtmh.1999.61.266","article-title":"Comparative study on the ability of IgG and F(ab\u2019)2 antivenoms to neutralize lethal and myotoxic effects induced by Micrurus nigrocinctus (coral snake) venom","volume":"61","author":"Le\u00f3n","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2023.107206_bib43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.toxicon.2018.06.084","article-title":"Current technology for the industrial manufacture of snake antivenoms","volume":"151","author":"Le\u00f3n","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2023.107206_bib44","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1007\/s11095-017-2219-y","article-title":"Influence of molecular size on the clearance of antibody fragments","volume":"34","author":"Li","year":"2017","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.toxicon.2023.107206_bib45","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/toxins14020122","article-title":"Local cytotoxic effects in cobra envenoming: a pilot study","volume":"14","author":"Lin","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2023.107206_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008054","article-title":"Pathogenesis of local necrosis induced by Naja atra venom: assessment of the neutralization ability of Taiwanese freeze-dried neurotoxic antivenom in animal models","volume":"14","author":"Liu","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.toxicon.2023.107206_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007014","article-title":"Development of sandwich ELISA and lateral flow strip assays for diagnosing clinically significant snakebite in Taiwan","volume":"12","author":"Liu","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.toxicon.2023.107206_bib48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11095-021-03022-y","article-title":"Machine learning attempts for predicting human subcutaneous bioavailability of monoclonal antibodies","volume":"38","author":"Lou","year":"2021","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.toxicon.2023.107206_bib49","doi-asserted-by":"crossref","first-page":"43496","DOI":"10.1074\/jbc.M307742200","article-title":"Tailoring in vitro selection for a picomolar affinity human antibody directed against vascular endothelial growth factor receptor 2 for enhanced neutralizing activity","volume":"278","author":"Lu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2023.107206_bib50","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/antib8040048","article-title":"Distinguishing between monomeric scFv and diabody in solution using light and small angle X-ray scattering","volume":"8","author":"L\u00fcdel","year":"2019","journal-title":"Antibodies"},{"key":"10.1016\/j.toxicon.2023.107206_bib51","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.toxicon.2020.08.002","article-title":"Comparison of F(ab\u2019)2 and Fab antivenoms in rattlesnake envenomation: first year's post-marketing experience with F(ab\u2019)2 in New Mexico","volume":"186","author":"Mascarenas","year":"2020","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2023.107206_bib52","first-page":"239","article-title":"A comparison of three methods for selecting values of input variables in the analysis of output from a computer code","volume":"21","author":"McKay","year":"1979","journal-title":"Technometrics"},{"key":"10.1016\/j.toxicon.2023.107206_bib53","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1021\/acs.molpharmaceut.1c00718","article-title":"Machine learning models for human in vivo pharmacokinetic parameters with in-house validation","volume":"18","author":"Miljkovi\u0107","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.toxicon.2023.107206_bib54","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0041-0101(94)90341-7","article-title":"Snake antivenoms from hyperimmunized horses: comparison of the antivenom activity and biological properties of their whole IgG and F(ab\u2019)2 fragments","volume":"32","author":"Morais","year":"1994","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2023.107206_bib55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.toxicon.2022.06.006","article-title":"Developing a computational pharmacokinetic model of systemic snakebite envenomation and antivenom treatment","volume":"215","author":"Morris","year":"2022","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2023.107206_bib56","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.4049\/jimmunol.172.4.2021","article-title":"Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn","volume":"172","author":"Ober","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.toxicon.2023.107206_bib57","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jconrel.2022.11.014","article-title":"Application of machine learning techniques to the analysis and prediction of drug pharmacokinetics","volume":"352","author":"Ota","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.toxicon.2023.107206_bib58","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.envsoft.2018.07.019","article-title":"Distribution-based sensitivity analysis from a generic input-output sample","volume":"108","author":"Pianosi","year":"2018","journal-title":"Environ. Model. Software"},{"key":"10.1016\/j.toxicon.2023.107206_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.envsoft.2015.01.004","article-title":"A simple and efficient method for global sensitivity analysis based on cumulative distribution functions","volume":"67","author":"Pianosi","year":"2015","journal-title":"Environ. Model. Software"},{"key":"10.1016\/j.toxicon.2023.107206_bib60","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.4049\/jimmunol.1000928","article-title":"Limits for antibody affinity maturation and repertoire diversification in hypervaccinated humans","volume":"187","author":"Poulsen","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.toxicon.2023.107206_bib61","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.bbrc.2005.07.002","article-title":"Demonstration of an in vivo generated sub-picomolar affinity fully human monoclonal antibody to interleukin-8","volume":"334","author":"Rathanaswami","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.toxicon.2023.107206_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxicon.2019.11.001","article-title":"Snakebite envenoming in French Guiana: assessment of the preclinical efficacy against the venom of Bothrops atrox of two polyspecific antivenoms","volume":"173","author":"Resiere","year":"2020","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2023.107206_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(24)36597-8","article-title":"Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: toward an optimization of antivenom therapy","volume":"281","author":"Rivi\u00e8re","year":"1997","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.toxicon.2023.107206_bib64","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0022-3565(24)37451-8","article-title":"Absorption and elimination of viper venom after antivenom administration","volume":"285","author":"Rivi\u00e8re","year":"1998","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.toxicon.2023.107206_bib65","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.addr.2020.05.009","article-title":"Predicting bioavailability of monoclonal antibodies after subcutaneous administration: open innovation challenge","volume":"167","author":"S\u00e1nchez-F\u00e9lix","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.toxicon.2023.107206_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256653","article-title":"Investigating myotoxicity following Australian red-bellied black snake (Pseudechis porphyriacus) envenomation","volume":"16","author":"Sanhajariya","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.toxicon.2023.107206_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10020073","article-title":"Pharmacokinetics of snake venom","volume":"10","author":"Sanhajariya","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2023.107206_bib68","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biologicals.2012.11.001","article-title":"Assessment of snake antivenom purity by comparing physicochemical and immunochemical methods","volume":"41","author":"Segura","year":"2013","journal-title":"Biologicals"},{"key":"10.1016\/j.toxicon.2023.107206_bib69","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.toxicon.2004.07.032","article-title":"Modelling Tityus scorpion venom and antivenom pharmacokinetics. Evidence of active immunoglobulin G's F(ab\u2019)2 extrusion mechanism from blood to tissues","volume":"44","author":"Sevcik","year":"2004","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2023.107206_bib70","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.intimp.2013.10.007","article-title":"Pharmacokinetics of Cryptelytrops purpureomaculatus (mangrove pit viper) venom following intravenous and intramuscular injections in rabbits","volume":"17","author":"Sim","year":"2013","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.toxicon.2023.107206_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41524-021-00614-5","article-title":"Evolutionary computational platform for the automatic discovery of nanocarriers for cancer treatment","volume":"7","author":"Stillman","year":"2021","journal-title":"npj Comput. Mater."},{"key":"10.1016\/j.toxicon.2023.107206_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41524-020-00366-8","article-title":"In silico modelling of cancer nanomedicine, across scales and transport barriers","volume":"6","author":"Stillman","year":"2020","journal-title":"npj Comput. Mater."},{"key":"10.1016\/j.toxicon.2023.107206_bib73","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3390\/toxins14080522","article-title":"Equatorial spitting cobra (Naja sumatrana) from Malaysia (negeri sembilan and penang), southern Thailand, and sumatra: comparative venom proteomics, immunoreactivity and cross-neutralization by antivenom","volume":"14","author":"Tan","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2023.107206_bib74","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/toxins8040086","article-title":"Neutralization of the principal toxins from the venoms of Thai Naja kaouthia and Malaysian hydrophis schistosus: insights into toxin-specific neutralization by two different antivenoms","volume":"8","author":"Tan","year":"2016","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2023.107206_bib75","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/0041-0101(88)90197-3","article-title":"Biological properties of Trimeresurus purpureomaculatus (shore pit viper) venom and its fractions","volume":"26","author":"Tan","year":"1988","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2023.107206_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9090290","article-title":"A review and database of snake venom proteomes","volume":"9","author":"Tasoulis","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2023.107206_bib77","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/0310057X19865268","article-title":"Australian snake antivenom dosing: what is scientific and safe?","volume":"48","author":"Tibballs","year":"2020","journal-title":"Anaesth. Intensive Care"},{"key":"10.1016\/j.toxicon.2023.107206_bib78","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1111\/bph.13504","article-title":"Effects of target binding kinetics on in vivo drug efficacy: koff, kon and rebinding","volume":"173","author":"Vauquelin","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.toxicon.2023.107206_bib79","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1074\/jbc.M806889200","article-title":"General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold","volume":"284","author":"Vincke","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2023.107206_bib80","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1021\/acs.bioconjchem.2c00220","article-title":"Generation of multivalent nanobody-based proteins with improved neutralization of long \u03b1-neurotoxins from elapid snakes","volume":"33","author":"Wade","year":"2022","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.toxicon.2023.107206_bib81","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/abt\/tbab003","article-title":"Optimization of therapeutic antibodies","volume":"4","author":"Wang","year":"2021","journal-title":"Antibody Therapeutics"},{"key":"10.1016\/j.toxicon.2023.107206_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.838082","article-title":"Research progress and applications of multivalent, multispecific and modified nanobodies for disease treatment","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.toxicon.2023.107206_bib83","series-title":"Initial Experience with F(ab\u2019)2 Antivenom Compared with Fab Antivenom for Rattlesnake Envenomations Reported to a Single Poison Center during 2019","author":"Wilson","year":"2022"},{"key":"10.1016\/j.toxicon.2023.107206_bib84","unstructured":"World Health Organisation, 2021. Snakebite envenoming [WWW Document]. URL https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/snakebite-envenoming (accessed 10.18.22)."},{"key":"10.1016\/j.toxicon.2023.107206_bib85","series-title":"Guidelines for the Management of Snakebites","year":"2016"},{"key":"10.1016\/j.toxicon.2023.107206_bib86","article-title":"Nanobodies: next generation of cancer diagnostics and therapeutics","volume":"10","author":"Yang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.toxicon.2023.107206_bib87","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.actatropica.2014.01.014","article-title":"Proteomic characterization of venom of the medically important Southeast Asian Naja sumatrana (Equatorial spitting cobra)","volume":"133","author":"Yap","year":"2014","journal-title":"Acta Trop."},{"key":"10.1016\/j.toxicon.2023.107206_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002890","article-title":"Pharmacokinetics of Naja sumatrana (equatorial spitting cobra) venom and its major toxins in experimentally envenomed rabbits","volume":"8","author":"Yap","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.toxicon.2023.107206_bib89","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.envsoft.2017.02.001","article-title":"Comparison of variance-based and moment-independent global sensitivity analysis approaches by application to the SWAT model","volume":"91","author":"Zadeh","year":"2017","journal-title":"Environ. Model. Software"},{"key":"10.1016\/j.toxicon.2023.107206_bib90","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/toxins8100299","article-title":"Proteomic characterization and comparison of Malaysian tropidolaemus wagleri and Cryptelytrops purpureomaculatus venom using shotgun-proteomics","volume":"8","author":"Zainal Abidin","year":"2016","journal-title":"Toxins"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010123001927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010123001927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:23:28Z","timestamp":1758576208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010123001927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":90,"alternative-id":["S0041010123001927"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2023.107206","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.03.13.532354","asserted-by":"object"}]},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global parameter optimisation and sensitivity analysis of antivenom pharmacokinetics and pharmacodynamics","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2023.107206","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107206"}}